Deccan Health Care Stock Screener | Share Price & Fundamental Analysis

DECCAN Healthcare Service Provider
Share Price BSE
₹11.75
▲ 0.54 (4.82%)
2026-04-13 00:00:00
As of April 13, 2026, the Deccan Health Care share price (BSE: DECCAN) is ₹11.75, up 4.82% from the previous close, with shares trading between ₹10.65 and ₹11.77, and a 52-week range of ₹6.85–₹23.09. Browse Deccan Health Care financial data to support your investment research. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Deccan Health Care Market Cap ₹27.28 Cr.
DECCAN P/E Ratio (TTM) 12.18
Deccan Health Care P/B Ratio 0.25
EPS (TTM) ₹0.54
Dividend Yield -
Debt to Equity 0.01
DECCAN 52 Week High ₹23.09
Deccan Health Care 52 Week Low ₹6.85
Operating Margin 10.00%
Profit Margin 5.88%
DECCAN Revenue (TTM) ₹17.00
EBITDA ₹2.00
Net Income ₹1.00
Total Assets ₹125.00
Total Equity ₹106.00

Deccan Health Care Share Price History - Stock Screener Chart

Screen DECCAN historical share price movements with interactive charts. Analyze price trends and patterns.

Deccan Health Care Company Profile - Fundamental Screener

Screen Deccan Health Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DECCAN shares.
Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E
ISIN INE452W01019

Deccan Health Care Balance Sheet Screener

Screen DECCAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021
Assets
Total Assets 125 108 97 91 92
Current Assets 106 88 76 68 67
Fixed Assets 14 16 17 19 20
Liabilities
Total Liabilities 0 0 0 0 0
Current Liabilities 3 4 4 3 3
Non-Current Liabilities 0 0 0 0 0
Shareholders' Equity
Total Equity 106 97 82 77 77
Share Capital 23 20 17 16 16
Reserves & Surplus 82 75 65 61 61

Deccan Health Care Income Statement Screener - Profit & Revenue Analysis

Screen Deccan Health Care income statement and profit fundamentals. Analyze DECCAN quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Deccan Health Care share price evaluation.
Item 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec 2022-Sept 2022-Jun
Revenue 17 21 22 21 20 19 15 16 15 17 11 16 9 12 9
Expenses 16 20 21 20 20 18 14 15 14 16 10 15 9 11 8
EBITDA 2 2 1 1 1 1 1 1 1 1 1 1 0 1 1
Operating Profit % 10.00% 8.00% 3.00% 3.00% 3.00% 6.00% 6.00% 4.00% 8.00% 6.00% 7.00% 5.00% -2.00% 7.00% 7.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 0 0 0 1 1 0 1 1 0 0 -1 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 1 1 0 0 0 1 0 0 1 1 0 0 -1 0 0
EPS 0.41 0.37 0.10 0.05 0.07 0.26 0.18 0.06 0.29 0.32 0.18 0.16 -0.27 0.17 0.13

Deccan Health Care Cash Flow Screener - Liquidity Fundamentals

Screen DECCAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March
Operating Activities -6 -13 -7 -1 0
Investing Activities 0 0 0 0 0
Financing Activities 8 14 5 0 0
Net Cash Flow 1 1 -1 -1 0

Deccan Health Care Shareholding Pattern Screener

See Deccan Health Care shareholding pattern with promoter, FII, and DII holdings. Check Deccan Health Care promoter holding and ownership changes for DECCAN on TickJournal.
Item 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Oct 2024-Sept 2024-Jun
Promoter Holding 18.42% 18.42% 18.42% 19.46% 18.26% 18.95% 15.66% 16.12%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 5.37% 5.37% 5.37% 5.68% 5.87% 6.09% 6.34% 6.53%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 46.36% 46.40% 46.53% 47.83% 48.92% 47.51% 49.44% 50.78%
Other Holding 29.84% 29.81% 29.68% 27.03% 26.95% 27.45% 28.57% 26.57%
Shareholder Count 3,926 3,743 3,667 3,614 3,416 3,154 3,154 3,002

Deccan Health Care Share Dividend Screener - Share Yield Analysis

Check Deccan Health Care dividend history with payout and yield data. View Deccan Health Care dividend details including ex-dates and amounts for DECCAN stock.
No dividends declared by Deccan Health Care.

Deccan Health Care Stock Index Membership

See which indices include Deccan Health Care stock. Check DECCAN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Deccan Health Care is not part of any tracked indices.
Only major market indices are tracked in our system.

Deccan Health Care Market Events Screener - Corporate Actions

Get Deccan Health Care corporate actions including splits, bonuses, and buybacks. Check Deccan Health Care stock events that may affect DECCAN share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 3.44%
Annual General Meeting NA -5.82%
2026-02-13 2026-02-13 Quarterly Result Announcement NA 0.29%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -3.95%
2025-08-14 2025-08-14 Quarterly Result Announcement NA -6.94%
2025-07-09 2025-07-09 Extraordinary General Meeting NA 0.89%
2025-05-29 2025-05-29 Quarterly Result Announcement NA 1.46%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -11.49%
2024-11-14 2024-11-14 Quarterly Result Announcement NA 3.23%

Deccan Health Care Competitors Screener - Peer Comparison

Screen DECCAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 23,361 44.08 2,555 11.28% 492 60.71
Vijaya Diagnostic Centre 10,044 63.10 700 23.06% 144 62.23
Metropolis Healthcare 9,550 57.32 1,346 10.64% 146 58.88
Thyrocare Technologies 6,285 46.76 702 20.80% 91 60.09
Nephrocare Health Services 5,763 78.04 770 33.97% 67 56.24
Krsnaa Diagnostics 1,918 24.10 743 16.70% 78 50.38
Suraksha Diagnostic 1,411 44.50 256 15.11% 31 60.86
One Global Service Provider 1,132 18.72 148 134.60% 19 52.94
3B BlackBio DX 1,039 18.04 112 28.72% 48 44.85
Sastasundar Ventures 862 29.47 1,171 -18.47% -134 43.80

Deccan Health Care Company Announcements - News Screener

Screen DECCAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-03-24 Closure of Trading Window -
2026-03-10 Announcement under Regulation 30 (LODR)-Resignation of Director -
2026-02-16 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-13 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-02-13 Board Meeting Outcome for Considered And Approved Standalone And Consolidated Financial Results For Quarter Ended 31.12.2025 -
2026-02-10 Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Result For The Quarter Ended 31St December 2025 And To Consider And Approve Appointment Of Independent Director(S) -
2026-01-21 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-01-10 Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer -
2025-12-27 Closure of Trading Window -
2025-12-11 Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E 11Th December 2025 -
2025-12-08 Board Meeting Intimation for Appointment Of Independent Directors -
2025-12-04 Disclosure under Regulation 30A of LODR -
2025-12-03 Disclosure under Regulation 30A of LODR -
2025-11-15 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-11-14 Announcement under Regulation 30 (LODR)-Investor Presentation -
2025-11-14 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2025-11-14 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2025-11-14 Approval Of Unaudited Financial Results For Quarter Ended Sep-25 -
2025-11-14 Board Meeting Outcome for Out Of Board Meeting For Approval Of Financial Results For Quarter Ended 30Th September 2025 -
2025-11-10 Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results (Standalone & Consolidated) Along With The Limited Review Report Thereon For The Half Year Ended 30 September 2025. -